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Objective. The concept of forced exercise has drawn attention for the treatment of Parkinson’s disease symptoms with anecdotal
reports of success. This study sought to ascertain any significant effect of forced exercise using a motorized stationary bicycle when
compared to controls on Parkinson’s disease symptoms in a blinded, randomized, and controlled setting. Setting. Parkinson’s disease
outpatient clinic, Veterans Administration Medical Center. Method. We assessed 23 patients (13 experimental and 10 controls) on
a number of standard Parkinson’s measures at baseline, after participation in eight weeks of twice weekly forced exercise or eight
weeks of conventional clinic care, and then after a three-month period had elapsed. Dependent measures were UPDRS-III, Berg
Balance Scale, finger taping test, and the PDQ-39. Results. Results did not demonstrate any main effect differences between the
exercise and control groups on any measure at any point in time. A within subjects effect was demonstrated for the forced exercise
group on overall UPDRS-III scores at the three-month end point. No other within group effects were noted. Results suggest that
early enthusiasm for forced exercise may need tempering. Limitations of the study are discussed as well as numerous logistical
challenges to this type of study.

1. Introduction
Exercise therapy is well known to be beneficial for the elderly
in general [1–4], and more recently the benefit of exercise for
patients with Parkinson’s disease (PD) has been investigated
[5–8]. The exact pathophysiological mechanism of exercise
and types of specific exercises beneficial to persons with
PD is still open to question [9]. Although there are limited
exercise studies involving persons with Parkinson’s [10], some
[11] postulate that the benefit of exercise is associated with
synaptic plasticity, cascading effect of growth factors, and by
reducing ancillary conditions (e.g., hypertension) that may
adversely impact the brain.
One limiting factor in studying the effect of exercise has
been the ability of the patient with PD to maintain sufficient exercise intensity to produce appreciable benefit to the
patient. Exercise intensity in this population can be limited by

a number of factors to include bradykinesia and imbalance as
well as general deconditioning. Recent studies [12, 13] have
tried to overcome these limiting factors by the use of tandem
bicycles (where the patient is placed in the rear seat and a fit
trainer in the front seat maintains a strict cadence of at least 80
revolutions-per-minute (rpm)). Thus the person with PD is
“forced” to maintain a higher than usually achievable level of
exercise. Even more recently, motorized single seat stationary
bicycles have been used for individuals with PD to maintain
a forced-exercise (FE) level without the need of a trainer [14].
Researchers [12] have examined the impact of FE on
the Unified Parkinson’s Disease Rating Scale (UPDRS) Part
III (motor component) scores and on bimanual dexterity
grasping tasks. They found that both the voluntary exercise
and forced exercise groups improved aerobically but only the
FE group experienced an improved UPDRS score and better
bilateral manual dexterity.
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Persons with PD and Parkinson’s researchers alike have
been intrigued by the relatively recent news of a possible
relationship between PD motor symptoms and bicycling. A
Danish researcher found that bicycling is a preserved motor
activity for persons with PD [13] while others have noted
the beneficial impact of relatively high intensity cycling on
tremors [12]. However due to the relative freshness of these
findings, limited formal studies have been conducted.
Consequently, our group conducted a small sample study
to examine the impact of cycling on various Parkinson’s
symptoms with the intent to expand the study to a much
larger sample in the next phase. In addition to examining the
impact of cycling FE on PD symptoms in a more systemized
manner, we also investigated the difficulties that could be
anticipated if conducting a rigorous, large-scale study of
cycling and PD.

2. Methods
Following local Institutional Review Board approval of
the study, subjects were recruited thorough hospital and
clinic advertisements at the Southeast Parkinson’s Disease
Research, Education and Clinical Center (PADRECC) of
the Richmond, Virginia Veterans Affair Medical Center. All
subjects had a three-year confirmed PD diagnosis with good
response to standard Parkinson’s medications and a UPDRS
Part III score of >30. Exclusion criteria were nonambulating
patients, demented patients, patients already enrolled in an
on-going PD drug research study, patients with uncontrolled
diabetes or hypertension, patients with chronic obstructive
pulmonary disease, and a history of coronary artery disease
or congestive heart failure.
After fully informed consent was obtained, 23 subjects
were randomly assigned to either an exercise group (𝑛 = 13)
or a control group (𝑛 = 10). All subjects were then evaluated
at baseline using the Berg Balance Scale (BBS) [15], Unified
Parkinson’s Disease rating Scale, Part III (UPDRS-III) [16],
finger taping test [17], and Parkinson’s Disability Questionnaire (PDQ-39) [18, 19].
Control and exercise subjects received usual PADRECC
clinic care involving medical visits (nursing, neurology,
physiatry, neuropsychology, and family support services) as
indicated and appropriate medication changes as necessary.
Those in the control group received no specialized physical
therapy or exercise conditioning. Exercisers underwent an
eight-week, twice weekly, cycling program with sessions consisting of warm-up, sustained 30 minute exercise, and cool
down, for a total of 16 FE sessions. Exercisers and controls
were reevaluated at the eight-week immediate postexercise
interval and then again after four months of exercise completion.
The Theracycle (RSS Industries, Inc., Franklin, MA, USA)
is a stationary bicycle with motorized pedals that can be
programmed to move at a selected speed without effort by the
rider. There are also moving handlebars designed to provide
an upper body exercise component. The handlebars were disabled and not used in this study as it was felt that the intensity
could be too intimidating for some subjects. FE intensity
was defined as 61–80% of the individual’s aerobic maximum
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target heart rate. Target heart rates were calculated using the
Karnoven formula (220-minus patient age = maximal heart
rate) [14]. Each FE participant participated in two supervised
sessions per week (Monday/Thursday or Tuesday/Friday) of
FE for eight consecutive weeks. Sessions consisted of a warmup period, followed by a 30-minute FE period in which the
targeted heart rate was maintained, followed by a cool down
period. While in the FE phase participants’ heart rates were
monitored by a trained research assistant using an Omron
HR-100C Heart Rate Monitor (Omron Healthcare, Inc., Lake
Forest, IL, USA).
On the day of and prior to exercise initiation, all subjects
were rated by a blinded neurologist using the UPDRS Part III.
Blinded evaluators administered the BBS as well. Evaluators,
all of whom had a bachelor’s or higher degree, were specially
trained by the principal investigator in administering these
tests. In addition a blinded neuropsychologist administered
the finger taping test for both dominant and nondominant
hand. Finally all participants completed the PDQ-39. Participants were evaluated using the same measures at the end of
the eight-week exercise period by the same blinded raters.
A third and final rating was administered four months after
the completion of exercise. Each evaluation took less than 45
minutes.
All evaluations were conducted while the subjects were in
the “on” state (within 3 hours) of medication. The “on” state
refers to the pulsatile nature of PD medications and wearing
off of effectiveness.
2.1. Measures. The BBS is an objective measure of balance
abilities. It has been used to identify and evaluate balance
impairment. The scale consists of 14 tasks common in everyday life. The items test a subject’s ability to maintain positions
or movements of increasing difficulty by diminishing the base
of support from sitting and standing to single-leg stance.
One’s ability to change positions is also assessed.
The UPDRS is currently the most widely accepted scale
for measuring the different components of PD. It is used in
clinical research and drug trials to follow the longitudinal
course of PD. Its major strength is that it provides a detailed
and accurate assessment of PD in different respects. It is
divided into 6 sections. For this study, we only used the scale’s
motor component (Part III). This is a detailed motor examination that evaluates 14 items with 27 distinct functions. Each
item is scored on a scale from 0 to 4. A total of 108 points are
possible, with 108 representing maximal (or total) disability
and 0 representing no disability.
In the finger taping test, subjects placed either hand palm
down, fingers extended, with the index finger on a metal lever
attached to a counting device. Individuals were told to press
the level to actuate the counter and then encouraged to “warm
up” at faster speeds until the correct technique was apparent
to them. The warm-up was then conducted on the other hand.
The Individuals were instructed to tap their index finger as
quickly as possible for ten seconds, keeping the hand and arm
stationary. This was followed by the alternate hand, and so
forth until three trials were completed for each hand. The test
takes approximately ten minutes to complete.
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The PDQ-39 is a validated, often used Parkinson’s disease
measure of health status. It consists of thirty-nine questions,
covering eight quality of life domains: Mobility, Activities of
daily living, Emotional well-being, Stigma, Social support,
Cognitions, Communication, and Bodily discomfort. A total
score is also tabulated. It has been widely used by researchers
all over the world.
2.2. Statistical Analysis. All analyses were conducted using
SPSS 16.0. As a main analysis, four one way ANOVAs were
conducted to determine if any between group differences
existed between the exercise and control groups on any
measure (UPDRS-III, BBS, Finger taping, or PDQ-39) at
any time point (baseline, immediate intervention, or at four
months). Statistical significance was set at the .05 level. As
a secondary analysis, within group analyses were also conducted using repeated-measures 𝑡-tests on the same four
dependent measures over the three time intervals.

3. Results
Participants were recruited via clinic flyers and word of
mouth. Forty-one patients were initially consented, but due
to an administrative error in applying exclusion criteria,
five were dropped due to PD onset of less than three years
and three were eliminated due to a MMSE of less than 23,
leaving a total of 33 active participants. Of this group, three
were dropped due to inability to get primary care physician
clearance, one died, and six left for medical reasons (hip pain
(2), knee pain (1), persistent fatigue (1), and missing exercise
sessions (2)). Four participants (three in the control group
and one experimental participant) failed to return for the
four-month follow-up. Participants had a mean age of 68.2
years (SD = 8.8 years, range 46–88 years) and a mean time of
PD onset of 7.2 years (SD = 6.2 years, range 3–29 years). Mean
age and mean time of onset did not differ between the control
and experimental groups.
Mean scores for both groups on all measures at all three
time intervals are included in Table 1. To analyze for a main
effect, four one-way ANOVAs (SPSS 16.0) were calculated for
the primary dependent measures (UPDRS-III BBS, Finger
taping, PDQ-39) at the endpoint (four-month follow-up)
to determine if significant treatment effects were present.
Results for the UPDRS-III (𝐹 = 1.75, 𝑃 = .20), BBS (𝐹 = .01,
𝑃 = .98), finger tap right (𝐹 = .347, 𝑃 = .56), finger tap left
(𝐹 = .04, 𝑃 = .84), and PDQ-39 (𝐹 = 2.02, 𝑃 = .18) were all
nonsignificant.
Similarly, the groups were examined using four one-way
ANOVAs at the immediate postexercise point (8 weeks) to
determine if differences existed. Results for the UPDRS-III
(𝐹 = .06, 𝑃 = .81), BBS (𝐹 = .001, 𝑃 = .97) Finger tap right
(𝐹 = .28, 𝑃 = .60), Finger tap left (𝐹 = .26, 𝑃 = .62) and
PDQ-39 (𝐹 = 3.57, 𝑃 = .07) were also all nonsignificant.
Within-subject effects were analyzed using ANOVA.
Only the experimental group’s UPDRS-III score demonstrated significant change over the course of the study (𝑃 =
.04). Posthoc analysis, using paired 𝑡-tests, indicated the
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significance occurred between baseline and four-month posttesting, not between baseline and immediate posttesting. No
other within-subject effects were found.

4. Discussion
No significant main effect differences were found between the
control and exercise groups on any of four measures at the
eight-week exercise point or at the four-month measurement
interval. This is of importance as our investigation compared
FE participants to a control group that had no specified
exercise routine, creating a more marked contrast in exercise
habits. Even with this heightened contrast no benefit on the
measurement instruments was demonstrated.
Our experimental group did show a significant within
group improvement on UPDRS-III scores at the four-month
period when compared to baseline. Improved UPDRS-III
scores have been previously reported with FE participants [12,
13]. Interestingly, the current study failed to show improvement at the immediate postexercise period but did show
improvement at the four-month follow-up point, whereas
previous studies showed an initial improvement that dissipated over time [13]. The reason for our exercise participants
showing a “delayed” improvement is counter-intuitive and
requires further investigation.
This study roughly utilized sample sizes and similar aged
participants to prior studies, but our participants had mean
onset time of PD symptoms over seven years, whereas some
[13] examined individuals with much shorter onset times. The
longer duration of onset in our sample may have added to
the general deconditioning effect seen with many individuals
with PD. One possible hypothesis is that the positive results
seen in other studies may be related to earlier exercise
interventions. In addition, our sample had a large range of
onset (26 years), creating the possibility that our sample was
much more heterogeneous than other samples studied. We
considered eliminating outliers but decided not to as the
sample studied is very representative of the clinic patients we
see daily.
As one of the first randomized, controlled investigations
attempting to study the feasibility of utilizing an outpatient
program of therapeutic exercise utilizing the Theracycle, this
study revealed a number of issues that should be considered
in future investigations. Although initial interest in the
protocol was high, recruitment of subjects was an on-going
challenge due to the duration of the study and the amount
of commitment required. Economic factors also played a role
as the cost to prospective subjects of twice weekly travel to
the hospital was too much for many who were on limited
incomes. This factor was greatly exacerbated by the upward
spiral in national gasoline prices that occurred during the
study period.
Use of the Karnoven formula also proved problematic in
those cases where subjects were taking beta-blockers, thus
making it impossible to reach target heart rates. Use of an
exertional formula, such as the Borg Rating of Perceived
Exertion Scale or the “talk-test” [20], would likely be more
utilitarian for this population.
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Table 1: Mean scores (and SD) of control and exercise groups.

UPDRS-III score
Range = 0–108
Time
Time
Time
1
2
3
15.7
14.2
10.4
Experimental
(6.2)
(8.4)
(4.8)
𝑛 = 13

Control
𝑛 = 10

16.9
(6.5)

15
(6.8)

14.1
(7.1)

BBS score
Range = 0–56
Time
Time
Time
1
2
3
47.6
46.8
48
(9.6)
(11.3)
(10. 4)

44
(9.6)

46.7
(8.2)

47.9
(7.2)

Finger tap R
Finger tap L
Mean taps per 10
Time
Time
Time
1
2
3
48.5
46.2
47
(8.8)
(11.4)
(10.4)
44.2
38
40.5
(9.3)
(9.1)
(8.5)
42.8
43.2
43.4
(13.7)
(14.0)
(15.4)
39.3
40.7
41.6
(14.4)
(14.7)
(14.5)

PDQ-39 total score
Range = 0–156
Time
Time
Time
1
2
3
34
29.8
30.6
(22.3)
(23.6)
(20.8)

62
(28.2)

50.3
(27.2)

48.7
(31.9)

Time 1: baseline; Time 2: immediate follow-up; Time 3: 4-month follow-up.
Higher UPDRS-III and PDQ-39 scores indicate more severe symptoms.
Time 3: three control participants and one experimental participant failed to return for follow-up testing.

Due to both their age and the years of inactivity partially caused by PD, many prospective subjects were either
exercise intolerant or incapable. The resultant overall patient
recruitment pattern could have potentially led to an unknown
selection bias with skewed results.
The PDQ-39 is the most widely used endpoint measure
for persons with Parkinson’s disease. However some [21] have
noted limitations inherent to the instrument. Specifically
attention has been drawn to the fact that the grouping of items
into subscales is “overly complex” and its meaning “unclear.”
With this in mind, we elected not to examine subscale scores,
although a case could perhaps be made for doing so and we
may have lost finer grain data.
Finally, this study was limited by small sample size, as well
as logistical issues and could be significantly improved upon
with a larger sample size and better subject adherence to the
study protocol, thus reducing selection biases in the current
study.

5. Conclusions
Prior reports of FE as a benefit to persons with Parkinson’s
disease are intriguing, but this study failed to show significant
treatment effects when compared to controls. Aside from a
within subject improvement on UPDRS-III scores in the FE
group no benefit was seen from forced exercise on the motor
assisted cycle. Larger controlled studies are warranted, but
our investigation highlights a number of clinical and logistical
challenges that should be considered prior to undertaking
such studies.
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